Digoxin Oral Tablet 0.125Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Digoxin: Oral tablet (0.125mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6016.JPG
Digoxin 0.125mg Tab
Lannett Co Inc
Pill Identification: JSP 544 
Drug Image file DrugItem_19530.JPG
Digoxin 0.125mg Tab
Global Pharmaceuticals
Pill Identification: 981 

What is this Medicine?

DIGOXIN (di JOX in) is used to treat congestive heart failure and heart rhythm problems.

CVS Pharmacy Patient Statistics for Digoxin: Oral tablet(0.125mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Digoxin 0.125mg Tablet

NDC: 005271324
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Atrial Fibrillation, Heart Failure

Sometimes used for but not FDA approved for the following conditions:
Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT) Prophylaxis, Paroxysmal Supraventricular Tachycardia (PSVT)

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Protect from moisture
Digoxin 0.125mg Tablet
Drug Image file DrugItem_6016.JPG
Lannett Co Inc
Pill Identification: JSP 544 
Shape: round
Color: yellow

Reported Side Effects for Digoxin 0.125mg Tablet

Rapid Heart Rate Incidence:
0.8%*
Severity: MODERATE
Onset: EARLY
Abnormal Heart Rhythm Incidence:
0.8%*
Severity: MODERATE
Onset: EARLY
Suddenly Stopped Heart Incidence:
0.8%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
0.8%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
1.6%*
Severity: MODERATE
Onset: RAPID
Headache Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
3.3%*
Severity: SEVERE
Onset: EARLY
Nervousness Incidence:
3.3%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.9%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Digoxin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.